Brazilian Portuguese translation, cross‐cultural adaptation and reproducibility assessment of the modified Bristol Stool Form Scale for children

Jozala, Débora Rodrigues; Oliveira, Isabelle Stefan de Faria; Ortolan, Érika Veruska Paiva; Oliveira, Walmar Kerche de; Comes, Giovana Tuccille; Cassettari, Vanessa Mello Granado; Self, Mariella M.; Lourenção, Pedro Luiz Toledo de Arruda

doi:10.1016/j.jpedp.2018.04.006

Cited by 1 publication

(1 citation statement)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The effective rate is the number of participants who are effective (on average, at least one bowel movement in 3 days, stool softening, defecate unobstructed) divided by a total number of the group. Stool form will be measured according to the modified Bristol stool form scale (m-BSFS) (Table 3), which classifies the form of children's feces into 5 types from separate hard lumps (type 1) to entirely watery (type 5) [33,34]. Distress sensation measured in the range of 0-3 represents the intensity of distress during defecation, "0" means no cry or grimace, "1" means slight cry and grimace, "2" means medium cry and grimace, and "3" means hysterical cry and grimace.…”

Section: Secondary Outcomesmentioning

confidence: 99%

Pediatric Tuina for functional constipation in children: study protocol for a randomized controlled trail

Zhang

et al. 2022

Trials

View full text Add to dashboard Cite

Background Functional constipation (FC) is a common functional gastrointestinal disorder, which brings many negative impacts to the children’s daily life. Pediatric Tuina has been proved to be a potential therapy for FC. However, the evidence for its effectiveness and safety is insufficient due to the lack of high-quality study. This study aims to evaluate the efficacy and safety of pediatric Tuina for children with FC. Methods/design This study is a randomized, controlled, multicentre, clinical trial. We will include 176 children with FC from five hospitals. The participants will be randomly allocated into two groups: the pediatric Tuina group and the Medilac-Vita group. This study will include a 1-week actual treatment period and a 2-week follow-up period. Primary outcomes are weekly spontaneous bowel movements and weekly complete spontaneous bowel movements. The secondary outcomes are effective rate, stool form, distress sensation, and glycerine enema rate. The assessment will be performed each week. Adverse event will be monitored in the treatment period and follow-up period. Discussion This study is designed to evaluate the efficacy and safety of pediatric Tuina for children with FC, and we hypothesize that pediatric Tuina is more effective than probiotics. It will provide reliable evidence and support for the treatment of FC by pediatric Tuina. Trial registration This protocol was registered in the Chinese Clinical Trial Registry (ChiCTR2100046485).

show abstract

Section: Secondary Outcomesmentioning

confidence: 99%

Pediatric Tuina for functional constipation in children: study protocol for a randomized controlled trail

Zhang

et al. 2022

Trials

View full text Add to dashboard Cite

show abstract

Brazilian Portuguese translation, cross‐cultural adaptation and reproducibility assessment of the modified Bristol Stool Form Scale for children

Cited by 1 publication

References 17 publications

Pediatric Tuina for functional constipation in children: study protocol for a randomized controlled trail

Pediatric Tuina for functional constipation in children: study protocol for a randomized controlled trail

Contact Info

Product

Resources

About